JOHN MANNION: Open Payments
NPI 1437760725 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 22 payments from 4 companies in 2025. Trend: 2023 $648 · 2024 $716 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $238 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Braeburn Inc. | 2 | $42 |
| Indivior Inc. | 2 | $35 |
Products named: CAPLYTA, REXULTI, BRIXADI, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
